NFKB1 and triple-negative breast carcinoma: For instance, it has been shown that Vit-C at a very low concentration (5 μM), in combination with methotrexate (MTX), resulted in the activation of p38 in triple negative breast cancer (TNBC) [166]; and this, in turn, could further inhibit the NF-κB pathway.